The Korea Food and Drug Administration has taken a recall action due to crystallization occurring in children's fever syrup.

Reporter Kim SangJin / approved : 2024-05-27 03:45:38
  • -
  • +
  • 인쇄
Children's fever reducer which was recalled due to crystallization. (Photo: Korea Food and Drug Administration)

 

[Alpha Biz= Reporter Kim Sangjin] According to the Korea Food and Drug Administration, some syrup-type children's fever relievers sold in pharmacies have been found to contain crystallization, prompting a recall order.


On the 24th, according to the administration, certain products of "NaeRin Syrup (active ingredient: acetaminophen)" produced by TELCON RF PHARMACEUTICAL and sold by Kwangdong Pharmaceutical have exhibited crystallization in the liquid, leading to ongoing recall procedures by the distributors.

The products subject to recall have the manufacturing number 23001 and an expiration date of February 26, 2025.

An official from the administration stated, "We are currently investigating the cause of the crystallization."

 

Alphabiz Reporter Kim SangJin(letyou@alphabiz.co.kr)

어플

주요기사

Eastar Jet Founder Lee Sang-jik Acquitted in Hiring Irregularities Case on Appeal2025.11.06
SK & AWS Ulsan AI Data Center Plan Faces Delay as Ulsan Mipo Industrial Complex Excluded from Korea’s Distributed Energy Special Zone2025.11.06
Seoul High Prosecutors’ Office Launches Search of Ssangbangwool Group Subsidiary Amid Allegations of “Salmon & Soju Party” Witness Bribery in North-Korea Remittance Probe2025.11.06
National Pension Service of Korea to Support Elon Musk’s Compensation Package at Tesla; Opposes AI-Startup Investment Proposal2025.11.06
Hyundai Rotem Refutes Allegations of Supplying Faulty Locomotive Parts to Bangladesh2025.11.06
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사